Mass Spectrometry of Nucleic Acids
To the Editor: We read with interest the review by Kricka (1 ) on nucleic acid detection technologies, in which he mentioned that nucleic acids do not have any intrinsic properties for direct detection. In response to this, we would like to point out the determination of intrinsic molecular weights of nucleic acids using mass spectrometry (MS) has been widely accepted as one of the most accurate methods to detect nucleic acids (2 ) . Using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS, a mass resolution of 1 per 1000 and the detection of low femtomole quantities of DNA can be achieved routinely (3 ) . Nucleic acids ranging from 2 to 2000 nucleotides can be detected by using MALDI-TOF MS (4 ) . Because of the mass differences of the nucleobases, MS can also be used to analyze mixtures of different nucleic acid fragments without the use of any label (5 ) . Furthermore, in most cases, the separation of the fragments before MS measurements is not required. The minimum sample volume required for MALDI-TOF MS is only a few nanoliters (3 ). MS can, therefore, be easily linked to any miniaturization of sample processing. Typically, each mass spectroscopic measurement including acquisition and interpretation of mass spectrum takes Ͻ10 s. With the availability of automatic high-throughput MS systems that include sample preparation (6 ) , the cost-effectiveness of using MS to analyze nucleic acids has become comparable to other analytical techniques. Currently, the size of a MALDI-TOF mass spectrometer is similar to an immunoassay analyzer. However, as stated in a recent report (7 ) , the size of mass spectrometers can be substantially reduced. Together with the continued development of software for automated interpretation of mass spectra, MS has a great potential to become one of the most important analytical tools for clinical laboratories. Some of the current clinical applications of MS are (a) DNA sequencing (8 ); (b) detection of genetic variations such as single-nucleotide polymorphisms (9 ), microsatellites (10 ), short tandem repeats (11 ) , and small insertions/deletions; and (c) gene expression.
